ArticleJournal of personalized medicine2022

Could Long-Acting Cabotegravir-Rilpivirine Be the Future for All People Living with HIV? Response Based on Genotype Resistance Test from a Multicenter Italian Cohort.

Andrea De Vito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.